Home › Entities › business › Ligand Pharmaceuticals

Ligand Pharmaceuticals

biopharmaceutical company based out of La Jolla, California
Organization business Q22079533

Facts

9 properties
Instance of
business
Inception
September 1987[5]
Headquarters location
San Diego[3]
Country
United States[2]
Official website
www.ligand.com[6]
Industry
pharmaceutical industry[4]
Legal form
XTIQ[7]
Located in the administrative territorial entity
San Diego[1]
P14750
D12B-218F-8916-6603-40D1[8]
🏷️ Also known as
en Ligand Pharmaceuticals en Progenx ar ليغاند الدوائية fa لیگند ja リガンド・ファーマシューティカルズ
🔖 Identifiers · 9
ROR ID
02ed5f444
Legal Entity Identifier
5493008K7TB0IKP37H79
GRID ID
grid.418267.e
Crunchbase organization ID
ligand-pharmaceuticals
Freebase ID
/m/02h6msr
ISIN
US53220K5048
Microsoft Academic ID (discontinued)
2806205006
Ringgold ID
7107
Scilit organization ID
10925
📈 SEC EDGAR
Public · NYSE/NASDAQ
CIK 0000886163
View SEC filings →
⛏️ Lake Facts · open-dataset statements via 4ort-mint

From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.

OpenAlex IDP10283
I4210117915 2026-09-27 openalex (CC0 1.0)
CC0 1.0 (OpenAlex snapshot, openalex.org). Values as shipped.
⚖️ Sworn Facts · SEC filings
board memberfiled
Martine Zimmermann sec.gov ↗
officerfiled
Andrew Reardon (CLO & Secretary) sec.gov ↗
subsidiary · 11filed
Apeiron Biologics GmbH sec.gov ↗
CyDex Pharmaceuticals, Inc. sec.gov ↗
Ligand Holdings UK Ltd. sec.gov ↗
Ligand UK Development Limited sec.gov ↗
Ligand UK Limited sec.gov ↗
Metabasis Therapeutics, Inc. sec.gov ↗
Neurogen Corporation sec.gov ↗
Pfenex Inc. sec.gov ↗
Pharmacopeia, LLC sec.gov ↗
Seragen, Inc. sec.gov ↗
Vernalis Therapeutics, Inc. sec.gov ↗
Structured parse of sworn SEC fields only. Facts a model extracted from 8-K narrative text are not shown here — how we measure this.
📋 Recent SEC Filings · last 8
144
2026-11-02
 10-Q
2026-10-30
10-Q
 144
2026-10-30
 144
2026-10-30
 8-K
2026-10-29
8-K
2.02 results of operations9.01 financial statements and exhibits
4
2026-10-06
FORM 4
 4
2026-09-24
PRIMARY DOCUMENT
 8-K
2026-09-24
8-K
7.01 Regulation FD disclosure8.01 other events
🔗 Connections
Country 1
United States
Headquarters location 1
San Diego
Industry 1
pharmaceutical industry
Instance of 1
business
Press Enter · cited answer in seconds

Financials

Self-reported XBRL data from 17 annual filings
Revenue
$268.09M
▲ 60.4% YoY FY2025
Net Income
$124.45M
▲ 3186.6% YoY FY2025
Assets
$1.56B
▲ 65.7% YoY FY2025
EPS (diluted)
$6.13
▲ 2886.4% YoY FY2025
$0.00$73.72M$147.45M$221.17M$294.90M FY2009: $38.94M · NI -$1.95M (-5.0% margin)FY2010: $23.54M · NI -$10.37M (-44.1% margin)FY2011: $30.04M · NI $9.71M (32.3% margin)FY2012: $31.39M · NI -$527.0K (-1.7% margin)FY2013: $48.97M · NI $11.42M (23.3% margin)FY2014: $64.54M · NI $12.02M (18.6% margin)FY2015: $71.91M · NI $229.82M (319.6% margin)FY2016: $108.97M · NI -$1.64M (-1.5% margin)FY2017: $141.10M · NI $12.56M (8.9% margin)FY2018: $251.45M · NI $143.32M (57.0% margin)FY2019: $120.28M · NI $629.30M (523.2% margin)FY2020: $163.56M · NI -$2.98M (-1.8% margin)FY2021: $241.54M · NI $57.14M (23.7% margin)FY2022: $196.25M · NI -$33.36M (-17.0% margin)FY2023: $131.31M · NI $52.15M (39.7% margin)FY2024: $167.13M · NI -$4.03M (-2.4% margin)FY2025: $268.09M · NI $124.45M (46.4% margin) '09'11'13'15'17'19'21'23'25
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession 0000886163-26-000006

Related Entities

business United States

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . GRID. Retrieved . grid.ac. Provenance: wikidata.org.
  2. [1] ↑ . ror.org. Retrieved . ror.org. Provenance: wikidata.org.
  3. [3] ↑ . wikidata.org.
  4. [4] ↑ . wikidata.org.
  5. [5] ↑ . wikidata.org.
  6. [6] ↑ . wikidata.org.
  7. [7] ↑ . Retrieved . wikidata.org.
  8. [8] ↑ . wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Ligand Pharmaceuticals. Retrieved November 2, 2026, from https://4ort.xyz/entity/ligand-pharmaceuticals
MLA “Ligand Pharmaceuticals.” 4ort.xyz Knowledge Graph, 4ort.xyz, 2 Nov. 2026, https://4ort.xyz/entity/ligand-pharmaceuticals.
BibTeX @misc{4ortxyz_ligand-pharmaceuticals_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Ligand Pharmaceuticals}}, year = {2026}, url = {https://4ort.xyz/entity/ligand-pharmaceuticals}, note = {Accessed: 2026-11-02}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Ligand Pharmaceuticals — https://4ort.xyz/entity/ligand-pharmaceuticals (retrieved 2026-11-02)

Canonical URL: https://4ort.xyz/entity/ligand-pharmaceuticals · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 10w ago · Trivialist · 2026-08-22 view diff on Wikidata ↗
    Inception → —
    Country → United States
    Country → —
    P14750 → D12B-218F-8916-6603-40D1
    + 10 other properties edited (see Wikidata diff for full list)
    "/* wbcreateclaim-create:1| */ P14750: D12B-218F-8916-6603-40D1, [[:toollabs:quickstatements/#/batch/269256|batch #269256]]"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.